Bio Equivalency 20 Mgm Orfadin and 20 Mgm of Nitisonine

Clinical trial NCT04113772 · UNKNOWN

Trial details

NCT number: NCT04113772
Sponsor: Sutphin Drugs
Status: UNKNOWN
Phase: Not Applicable
Study type: INTERVENTIONAL

Hereditary Tyrosinemia, Type I

Start date: 2019-11-01
Primary completion: 2020-12-31
Enrollment: 4

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.